Senores Pharmaceuticals Ltd (SENORES)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 736.00
% Change: -1.34% (Prev Close: 746.00)

Volume: 2,48,794
% Change: -16.80% (Prev Volume: 2,99,049)

Delivery: 1,17,609
Delivery % : 47.27
% Change: -34.37% (Prev Delivery: 1,79,205)

Turnover: 1,839 Lacs
% Change: -16.36% (Prev Turnover: 2,199)

💹 EOD Valuation

P/E Ratio: 57.86
P/B Ratio: 4.31
Market Cap: 3393 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: SENORES
Market Cap: 3178 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 737.85
52 Week Low: 435.25

All-Time High: 737.85 Rs.
All-Time Low: 435.25 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
5.38% | 33.74% | 25.42% | 0.00% | 0.00%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 45.78%

Change (3Y | 1Y): 0.00% | 0.01%

Pledged %: 0.00%

FII Holding

FII Holding: 3.66%

Change (3Y | 1Y): 0.00% | -0.51%

DII Holding

DII Holding: 9.51%

Change (3Y | 1Y): 0.00% | -0.15%

Public Holding: 41.03%


🏦 Financial Strength

Debt to Equity: 0.40
Debt: 314.75 Rs. Cr.

Book Value: 170.71 Rs.
Current Ratio: 3.00
Interest Coverage: 4.27
Free Cash Flow: -203.44 Rs. Cr.


📈 Growth & Sales

Sales Growth: 85.65%

Sales Growth Qtr (YOY | QoQ):
71.65% | 20.82%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 204.04% | 85.65%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 86.03%

Profit Growth Qtr (YOY | QoQ):
83.88% | 17.86%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 289.63% | 86.03%


EPS Rs.

EPS (TTM): 12.72 Rs.

EPS Qtr (Last Year | Latest):
3.23 Rs. | 4.28 Rs.

EPS Annual (Last Annual | Annual March):
10.31 Rs. | 12.72 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
0.00% | 132.74%


Net Profit Rs. Cr.

Net Profit (TTM): 58.34 Rs. Cr.

Net Profit (Annual - March): 58.34 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
10.91| 17.97 | 21.18


EBITDA Rs. Cr.

EBITDA (Quarter): 37.52 Rs. Cr.
EBITDA (Previous Yr Ql): 21.80 Rs. Cr.

EBITDA (Annual - March): 108.96 Rs. Cr.
EBITDA (Previous Annual): 44.45 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
0.00% | 255.75%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 22.52%

OPM Qtr (Previous | Current):
17.02% | 24.76%

OPM Annual (5 Yrs | Last Yr | March):
0.00% | 19.41% | 22.52%


Return on Equity %

ROE: 11.82%

ROE (5 Yrs | 3 Yrs | Last Yr):
0.00% | 14.89% | 25.21%


Return on Capital Employed %

ROCE: 11.40%

ROCE (5 Yrs | 3 Yrs | Last Yr):
13.74% | 13.74% | 11.53%


Return on Assets %

ROA (TTM): 6.31%

ROA (5 Yrs | 3 Yrs | Last Yr):
0.00% | 7.96% | 8.69%



PEG Ratio: 0.19
Dividend Yield: 0.00%

PE 3 Yrs: 51.10
PE 5 Yrs: 51.10

Dividend Yield: 0.00%


👥 Company

Senores Pharmaceuticals Ltd

SENORES

Promoter Holding: %